SK Biopharm, Dong-A ST sign licensing deal of Cenobamate

South Korea's SK Biopharmaceuticals Co. announced on Thursday that it has signed a contract with Dong-A ST to transfer the rights to commercialize t...

SK Biopharm gears up to boost epilepsy drug sales in Europe

SK Biopharmaceuticals Co. is gearing up to explore the European market for its flagship epilepsy drug Cenobamate, while looking for new mergers and ...

Another Foreigner Detained in China, This Time a Korean Soccer Pro

SINGAPORE—Chinese police have detained a South Korean soccer player on allegations of bribery, the latest in a spate of enforcement actions af...

Terra co-founder Do Kwon’s $177 million assets in Korea under seizure

Terraform Labs co-founder Do Kwon, the mastermind behind the Terra-Luna cryptocurrency collapse, has had most of his assets in South Korea frozen, a...

SK Biopharmaceuticals wins Red Dot award for 2 devices

South Korea’s SK Biopharmaceuticals on Tuesday said two of its self-developed wearable devices won the main prize in the health care category ...

SK invests in US digital healthcare firm Cala Health

South Korea's SK Biopharmaceuticals Co. has dipped its toes into the rapidly growing digital healthcare market by investing in Cala Health, a US-bas...